Globus Medical Inc (GMED)
81.10
-1.44
(-1.74%)
USD |
NYSE |
Nov 14, 16:00
81.10
0.00 (0.00%)
Pre-Market: 05:48
Globus Medical Free Cash Flow (Quarterly): 161.70M for Sept. 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 161.70M |
| June 30, 2024 | 26.46M |
| March 31, 2024 | 23.82M |
| December 31, 2023 | 81.79M |
| September 30, 2023 | 28.95M |
| June 30, 2023 | 17.16M |
| March 31, 2023 | 37.32M |
| December 31, 2022 | 45.64M |
| September 30, 2022 | 20.94M |
| June 30, 2022 | 13.13M |
| March 31, 2022 | 24.72M |
| December 31, 2021 | 59.21M |
| September 30, 2021 | 59.47M |
| June 30, 2021 | 50.80M |
| March 31, 2021 | 49.90M |
| December 31, 2020 | 66.12M |
| September 30, 2020 | 35.92M |
| June 30, 2020 | 13.11M |
| March 31, 2020 | 19.98M |
| December 31, 2019 | 38.52M |
| September 30, 2019 | 43.80M |
| June 30, 2019 | 7.857M |
| March 31, 2019 | 11.05M |
| December 31, 2018 | 27.13M |
| September 30, 2018 | 36.42M |
| Date | Value |
|---|---|
| June 30, 2018 | 18.48M |
| March 31, 2018 | 39.92M |
| December 31, 2017 | 31.41M |
| September 30, 2017 | 21.98M |
| June 30, 2017 | 12.45M |
| March 31, 2017 | 41.92M |
| December 31, 2016 | 12.13M |
| September 30, 2016 | 36.10M |
| June 30, 2016 | 12.49M |
| March 31, 2016 | 46.19M |
| December 31, 2015 | 31.98M |
| September 30, 2015 | 18.57M |
| June 30, 2015 | -4.737M |
| March 31, 2015 | 27.44M |
| December 31, 2014 | -7.15M |
| September 30, 2014 | 32.22M |
| June 30, 2014 | 6.283M |
| March 31, 2014 | 23.07M |
| December 31, 2013 | 27.45M |
| September 30, 2013 | 28.04M |
| June 30, 2013 | 2.796M |
| March 31, 2013 | 11.50M |
| December 31, 2012 | 17.09M |
| September 30, 2012 | 11.72M |
| June 30, 2012 | 6.493M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
13.11M
Minimum
Jun 2020
161.70M
Maximum
Sep 2024
43.73M
Average
36.62M
Median
Free Cash Flow (Quarterly) Benchmarks
| Boston Scientific Corp | 698.00M |
| ResMed Inc | 305.93M |
| Stryker Corp | 1.304B |
| Abbott Laboratories | 2.149B |
| Haemonetics Corp | 39.39M |